Findings

What do systematic reviews say?

3 questions · 3 findings · 3 reviews · Neuromuscular

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 1 · 33.3%Very low 1 · 33.3%Low 1 · 33.3%Moderate 0 · 0%High 0 · 0%

Interferon beta‐1a vs placebo

Serious adverse events · people with CIDP

Interferon beta‐1a showed no clear difference in serious adverse events compared with placebo (low certainty).

1 finding from 1 review

Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory… 2017 · Cochrane Headline outcomes only
RR 4.5 [0.25, 80.05]
1 study · 67 participants
Low

Interferon beta‐1a vs placebo

Significant adverse events · people with inclusion body myositis

1 finding from 1 review

Treatment for inclusion body myositis 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 58 participants
GRADE not reported

Interferon beta‐1a vs placebo

Participants with 1 or more serious adverse events · patients with Guillain‐Barré syndrome

It is very uncertain whether interferon beta‐1a changes participants with 1 or more serious adverse events compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for… 2020 · Cochrane Headline outcomes only
RR 0.92 [0.23, 3.72]
1 study · 19 participants
Very low